5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates Lipid A endotoxin-induced inflammation

PLoS One. 2014 Jul 15;9(7):e102622. doi: 10.1371/journal.pone.0102622. eCollection 2014.

Abstract

The Lipid A moiety of endotoxin potently activates TLR-4 dependent host innate immune responses. We demonstrate that Lipid-A mediated leukotriene biosynthesis regulates pathogen-associated molecular patterns (PAMP)-dependent macrophage activation. Stimulation of murine macrophages (RAW264.7) with E. coli 0111:B4 endotoxin (LPS) or Kdo2-lipid A (Lipid A) induced inflammation and Lipid A was sufficient to induce TLR-4 mediated macrophage inflammation and rapid ERK activation. The contribution of leukotriene biosynthesis was evaluated with a 5-lipoxygenase activating protein (FLAP) inhibitor, MK591. MK591 pre-treatment not only enhanced but also sustained ERK activation for up to 4 hours after LPS and Lipid A stimulation while inhibiting cell proliferation and enhancing cellular apoptosis. Leukotriene biosynthesis inhibition attenuated inflammation induced by either whole LPS or the Lipid A fraction. These responses were regulated by inhibition of the key biosynthesis enzymes for the proinflammatory eicosanoids, 5-lipoxygenase (5-LO), and cyclooxygenase-2 (COX-2) quantified by immunoblotting. Inhibition of leukotriene biosynthesis differentially regulated TLR-2 and TLR-4 cell surface expression assessed by flow cytometry, suggesting a close mechanistic association between TLR expression and 5-LO associated eicosanoid activity in activated macrophages. Furthermore, MK591 pre-treatment enhanced ERK activation and inhibited cell proliferation after LPS or Lipid A stimulation. These effects were regulated in part by increased apoptosis and modulation of cell surface TLR expression. Together, these data clarify the mechanistic association between 5-lipoxygenase activating protein-mediated leukotriene biosynthesis and 5-LO dependent eicosanoid metabolites in mediating the TLR-dependent inflammatory response after endotoxin exposure typical of bacterial sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Lipoxygenase-Activating Protein Inhibitors / pharmacology*
  • 5-Lipoxygenase-Activating Proteins / physiology*
  • Animals
  • Apoptosis
  • Arachidonate 5-Lipoxygenase / biosynthesis
  • Cell Line
  • Cell Proliferation
  • Cell Survival / drug effects
  • Chemokine CXCL2 / metabolism
  • Indoles / pharmacology*
  • Leukotrienes / biosynthesis*
  • Lipid A / pharmacology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Quinolines / pharmacology*
  • Toll-Like Receptor 2 / metabolism
  • Toll-Like Receptor 4 / metabolism

Substances

  • 5-Lipoxygenase-Activating Protein Inhibitors
  • 5-Lipoxygenase-Activating Proteins
  • Alox5ap protein, mouse
  • Chemokine CXCL2
  • Cxcl2 protein, mouse
  • Indoles
  • Leukotrienes
  • Lipid A
  • Quinolines
  • Tlr2 protein, mouse
  • Tlr4 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • MK 0591
  • Arachidonate 5-Lipoxygenase

Grants and funding

The work was supported in part by Taiwan National Science Council Grant (NSC 97-2314-B-182A-082-, NSC 101-2314-B-182A-094-), MSD IISP (Investigator-Initiated Study Program #37346), and Chang Gung Memorial Hospital Grant (CMRPG890661, CMRPG890662, CMRPG8C0551) to Wen-Feng Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.